Shelley E. Ackerman
Impact in
- Epidemiology top 10%
- Adipokines, Inflammation, and Metabolic Diseases
- Pneumonia and Respiratory Infections
-
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 2
- Co-authors
- Tracey McLaughlin (1 shared paper)Lei Shen (1 shared paper)Edgar G. Engleman (5 shared papers)Jennifer R. Cochran (3 shared papers)Nicolas Currier (2 shared papers)Bevin P. Engelward (1 shared paper)Vincent Chow (1 shared paper)Jimmy Kwang (1 shared paper)
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (1 paper)Immunology (1 paper)Journal of Clinical Investigation (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesSingaporeChina
In The Last Decade
Shelley E. Ackerman
11 papers receiving 557 citations
Shelley E. Ackerman's Hit Papers
Peers
Comparison fields: 5 of 81
- Epidemiology 213
- Immunology 124
- Physiology 117
- Microbiology 18
- Infectious Diseases 47
Countries citing papers authored by Shelley E. Ackerman
This map shows the geographic impact of Shelley E. Ackerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelley E. Ackerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelley E. Ackerman more than expected).
Fields of papers citing papers by Shelley E. Ackerman
This network shows the impact of papers produced by Shelley E. Ackerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelley E. Ackerman. The network helps show where Shelley E. Ackerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Shelley E. Ackerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Role of innate and adaptive immunity in obesity-associated metabolic disease Hit paper breakdown → | 2017 | 363 |
| 2 | 2015 | 111 | |
| 3 | 2014 | 38 | |
| 4 | 2016 | 31 | |
| 5 | 2019 | 10 | |
| 6 | 2020 | 5 | |
| 7 | 2014 | 4 | |
| 8 | 2019 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2021 | 0 |
About Shelley E. Ackerman
Shelley E. Ackerman is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 13 papers that have together received 567 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cell Adhesion Molecules Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Epidemiology (213 citations), Immunology (124 citations), Physiology (117 citations), Microbiology (18 citations) and Infectious Diseases (47 citations). Shelley E. Ackerman has collaborated with scholars based in United States, Singapore and China. Frequent co-authors include Tracey McLaughlin, Lei Shen, Edgar G. Engleman, Jennifer R. Cochran, Nicolas Currier, Bevin P. Engelward, Vincent Chow, Jimmy Kwang, Na Li and Fang He. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Immunology, Journal of Clinical Investigation and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.